Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Nian

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Advanced Materials (Deerfield Beach, Fla.)|February 8, 2019
Over 12% Efficiency Nonfullerene All-Small-Molecule Organic Solar Cells with Sequentially Evolved Multilength Scale MorphologiesKe Gao, Sae Byeok Jo, Xueliang Shi, et al.
Frontiers in Immunology|May 8, 2023
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cellsYang Liu, Xingxing Jie, Li Nian, et al.
Nature Communications|July 1, 2022
Traps and transport resistance are the next frontiers for stable non-fullerene acceptor solar cellsChristopher Wöpke, Clemens Göhler, Maria Saladina, et al.
Nature Communications|August 2, 2022
Author Correction: Traps and transport resistance are the next frontiers for stable non-fullerene acceptor solar cellsChristopher Wöpke, Clemens Göhler, Maria Saladina, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Advanced Materials (Deerfield Beach, Fla.)|February 8, 2019
Over 12% Efficiency Nonfullerene All-Small-Molecule Organic Solar Cells with Sequentially Evolved Multilength Scale MorphologiesKe Gao, Sae Byeok Jo, Xueliang Shi, et al.
Frontiers in Immunology|May 8, 2023
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cellsYang Liu, Xingxing Jie, Li Nian, et al.
Nature Communications|July 1, 2022
Traps and transport resistance are the next frontiers for stable non-fullerene acceptor solar cellsChristopher Wöpke, Clemens Göhler, Maria Saladina, et al.
Nature Communications|August 2, 2022
Author Correction: Traps and transport resistance are the next frontiers for stable non-fullerene acceptor solar cellsChristopher Wöpke, Clemens Göhler, Maria Saladina, et al.
Pageof 6